BioNexus Gene Lab Corp
(NASDAQ: BGLC)
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
4.100
-0.230
(-5.31%)
Range
4.061 - 4.180
(2.93%)
Open
4.080
Previous Close
4.330
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
30,273
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis